Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up.
Olsson SE, Restrepo JA, Reina JC, Pitisuttithum P, Ulied A, Varman M, Van Damme P, Moreira ED Jr, Ferris D, Block S, Bautista O, Gallagher N, McCauley J, Luxembourg A. Olsson SE, et al. Among authors: gallagher n. Papillomavirus Res. 2020 Dec;10:100203. doi: 10.1016/j.pvr.2020.100203. Epub 2020 Jul 11. Papillomavirus Res. 2020. PMID: 32659510 Free PMC article. Clinical Trial.
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial.
Thiem VD, Quang ND, Tuan NH, Cheon K, Gallagher N, Luxembourg A, Group T, Badshah C. Thiem VD, et al. Among authors: gallagher n. Hum Vaccin Immunother. 2021 Jul 3;17(7):1980-1985. doi: 10.1080/21645515.2020.1865739. Epub 2021 Apr 12. Hum Vaccin Immunother. 2021. PMID: 33844623 Free PMC article. Clinical Trial.
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial.
Platt H, Omole T, Cardona J, Fraser NJ, Mularski RA, Andrews C, Daboul N, Gallagher N, Sapre A, Li J, Polis A, Fernsler D, Tamms G, Xu W, Murphy R, Skinner J, Joyce J, Musey L. Platt H, et al. Among authors: gallagher n. Lancet Infect Dis. 2023 Feb;23(2):233-246. doi: 10.1016/S1473-3099(22)00526-6. Epub 2022 Sep 15. Lancet Infect Dis. 2023. PMID: 36116461 Clinical Trial.
Knowledge, attitudes, and practices of US travelers to Asia regarding seasonal influenza and H5N1 avian influenza prevention measures.
Yanni EA, Marano N, Han P, Edelson PJ, Blumensaadt S, Becker M, Dwyer S, Crocker K, Daley T, Davis X, Gallagher N, Balaban V, McCarron M, Mounts A, Lipman H, Brown C, Kozarsky P. Yanni EA, et al. Among authors: gallagher n. J Travel Med. 2010 Nov-Dec;17(6):374-81. doi: 10.1111/j.1708-8305.2010.00458.x. J Travel Med. 2010. PMID: 21050316 Free article.
On the treatment of airline travelers in mathematical models.
Johansson MA, Arana-Vizcarrondo N, Biggerstaff BJ, Staples JE, Gallagher N, Marano N. Johansson MA, et al. Among authors: gallagher n. PLoS One. 2011;6(7):e22151. doi: 10.1371/journal.pone.0022151. Epub 2011 Jul 25. PLoS One. 2011. PMID: 21799782 Free PMC article.
406 results